{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,5]],"date-time":"2025-10-05T20:01:24Z","timestamp":1759694484034},"reference-count":84,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2021,2,1]],"date-time":"2021-02-01T00:00:00Z","timestamp":1612137600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,2,1]],"date-time":"2021-02-01T00:00:00Z","timestamp":1612137600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Curr Hypertens Rep"],"published-print":{"date-parts":[[2021,2]]},"DOI":"10.1007\/s11906-021-01130-z","type":"journal-article","created":{"date-parts":[[2021,2,27]],"date-time":"2021-02-27T02:02:41Z","timestamp":1614391361000},"update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["To Curb the Progression of Fatal COVID-19 Course\u2014Dream or Reality"],"prefix":"10.1007","volume":"23","author":[{"given":"Szymon","family":"Price","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rados\u0142aw","family":"Targo\u0144ski","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Janusz","family":"Sadowski","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ryszard","family":"Targo\u0144ski","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2021,2,27]]},"reference":[{"key":"1130_CR1","doi-asserted-by":"publisher","first-page":"1054","DOI":"10.1016\/S0140-6736(20)30566-3","volume":"395","author":"F Zhou","year":"2020","unstructured":"Zhou F, Yu T, Du R, Fan G, Liu Y, Liu Z, et al. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet. 2020;395:1054\u201362. https:\/\/doi.org\/10.1016\/S0140-6736(20)30566-3.","journal-title":"Lancet"},{"key":"1130_CR2","doi-asserted-by":"publisher","unstructured":"Petrilli CM, Jones SA, Yang J, Rajagopalan H, O'Donnell LF, Chernyak Y, Tobin K, Cerfolio RJ, Francois F, Horwitz LI. Factors associated with hospitalization and critical illness among 4,103 patients with COVID-19 disease in New York City. medRxiv 2020; : 2020.04.08.20057794. https:\/\/doi.org\/10.1101\/2020.04.08.20057794","DOI":"10.1101\/2020.04.08.20057794"},{"key":"1130_CR3","doi-asserted-by":"publisher","first-page":"2221","DOI":"10.2147\/DMSO.S216791","volume":"12","author":"W Kopp","year":"2019","unstructured":"Kopp W. How western diet and lifestyle drive the pandemic of obesity and civilization diseases. Diabetes, Metab Syndr Obes Targets Ther. 2019;12:2221\u201336. https:\/\/doi.org\/10.2147\/DMSO.S216791.","journal-title":"Diabetes, Metab Syndr Obes Targets Ther"},{"key":"1130_CR4","doi-asserted-by":"publisher","first-page":"R706","DOI":"10.1152\/ajpregu.00250.2017","volume":"313","author":"A Kirabo","year":"2017","unstructured":"Kirabo A. A new paradigm of sodium regulation in inflammation and hypertension. Am J Phys Regul Integr Comp Phys. 2017;313:R706\u201310. https:\/\/doi.org\/10.1152\/ajpregu.00250.2017.","journal-title":"Am J Phys Regul Integr Comp Phys"},{"key":"1130_CR5","doi-asserted-by":"publisher","unstructured":"Targo\u0144ski R, Sadowski J, Price S, Targo\u0144ski R. Sodium-induced inflammation\u2014an invisible player in resistant hypertension. Hypertens Res e-pub ahead of print 2020; https:\/\/doi.org\/10.1038\/s41440-020-0428-y.","DOI":"10.1038\/s41440-020-0428-y"},{"key":"1130_CR6","doi-asserted-by":"publisher","first-page":"2059","DOI":"10.1016\/S0140-6736(15)00257-3","volume":"386","author":"B Williams","year":"2015","unstructured":"Williams B, MacDonald TM, Morant S, Webb DJ, Sever P, McInnes G, et al. Spironolactone versus placebo, bisoprolol, and doxazosin to determine the optimal treatment for drug-resistant hypertension (PATHWAY-2): a randomised, double-blind, crossover trial. Lancet (London, England). 2015;386:2059\u201368. https:\/\/doi.org\/10.1016\/S0140-6736(15)00257-3.","journal-title":"Lancet (London, England)"},{"key":"1130_CR7","doi-asserted-by":"publisher","first-page":"464","DOI":"10.1016\/S2213-8587(18)30071-8","volume":"6","author":"B Williams","year":"2018","unstructured":"Williams B, MacDonald TM, Morant SV, Webb DJ, Sever P, McInnes GT, et al. Endocrine and haemodynamic changes in resistant hypertension, and blood pressure responses to spironolactone or amiloride: the PATHWAY-2 mechanisms substudies. Lancet Diabetes Endocrinol. 2018;6:464\u201375. https:\/\/doi.org\/10.1016\/S2213-8587(18)30071-8.","journal-title":"Lancet Diabetes Endocrinol"},{"key":"1130_CR8","doi-asserted-by":"publisher","first-page":"1092","DOI":"10.1016\/S0140-6736(18)31943-3","volume":"392","author":"S Oparil","year":"2018","unstructured":"Oparil S, Fu RH. Revisiting ASCOT 16 years later. Lancet (London, England). 2018;392:1092\u20134. https:\/\/doi.org\/10.1016\/S0140-6736(18)31943-3.","journal-title":"Lancet (London, England)"},{"key":"1130_CR9","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1161\/HYPERTENSIONAHA.116.07289","volume":"68","author":"CL Laffer","year":"2016","unstructured":"Laffer CL, Scott RC 3rd, Titze JM, Luft FC, Elijovich F. Hemodynamics and salt-and-water balance link sodium storage and vascular dysfunction in salt-sensitive subjects. Hypertens (Dallas, Tex 1979). 2016;68:195\u2013203. https:\/\/doi.org\/10.1161\/HYPERTENSIONAHA.116.07289.","journal-title":"Hypertens (Dallas, Tex 1979)"},{"key":"1130_CR10","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1038\/s41586-020-2012-7","volume":"579","author":"P Zhou","year":"2020","unstructured":"Zhou P, Yang X-L, Wang X-G, Hu B, Zhang L, Zhang W, et al. A pneumonia outbreak associated with a new coronavirus of probable bat origin. Nature. 2020;579:270\u20133. https:\/\/doi.org\/10.1038\/s41586-020-2012-7.","journal-title":"Nature"},{"key":"1130_CR11","doi-asserted-by":"publisher","first-page":"2605","DOI":"10.1161\/CIRCULATIONAHA.104.510461","volume":"111","author":"M FC","year":"2005","unstructured":"FC M, Jewell J, CM C, AD B, Bridget BK, Ann TE, et al. Effect of angiotensin-converting enzyme inhibition and angiotensin II receptor blockers on cardiac angiotensin-converting enzyme 2. Circulation. 2005;111:2605\u201310. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.104.510461.","journal-title":"Circulation"},{"key":"1130_CR12","doi-asserted-by":"publisher","first-page":"410","DOI":"10.1007\/s11906-008-0076-0","volume":"10","author":"MJ Soler","year":"2008","unstructured":"Soler MJ, Barrios C, Oliva R, Batlle D. Pharmacologic modulation of ACE2 expression. Curr Hypertens Rep. 2008;10:410\u20134. https:\/\/doi.org\/10.1007\/s11906-008-0076-0.","journal-title":"Curr Hypertens Rep"},{"key":"1130_CR13","doi-asserted-by":"publisher","unstructured":"\u2022\u2022 Mancia G, Rea F, Ludergnani M, Apolone G, Corrao G. Renin-angiotensin-aldosterone system blockers and the risk of Covid-19. N Engl J Med. 2020:1\u201310. https:\/\/doi.org\/10.1056\/NEJMoa2006923This paper evaluated the risk of COVID-19 in patients on various antihypertensive agents.","DOI":"10.1056\/NEJMoa2006923"},{"key":"1130_CR14","doi-asserted-by":"publisher","first-page":"875","DOI":"10.1038\/nm1267","volume":"11","author":"K Kuba","year":"2005","unstructured":"Kuba K, Imai Y, Rao S, Gao H, Guo F, Guan B, et al. A crucial role of angiotensin converting enzyme 2 (ACE2) in SARS coronavirus-induced lung injury. Nat Med. 2005;11:875\u20139. https:\/\/doi.org\/10.1038\/nm1267.","journal-title":"Nat Med"},{"key":"1130_CR15","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1038\/nature03712","volume":"436","author":"Y Imai","year":"2005","unstructured":"Imai Y, Kuba K, Rao S, Huan Y, Guo F, Guan B, et al. Angiotensin-converting enzyme 2 protects from severe acute lung failure. Nature. 2005;436:112\u20136. https:\/\/doi.org\/10.1038\/nature03712.","journal-title":"Nature"},{"key":"1130_CR16","doi-asserted-by":"publisher","first-page":"781","DOI":"10.1097\/HJH.0000000000002450","volume":"38","author":"M Esler","year":"2020","unstructured":"Esler M, Esler D. Can angiotensin receptor-blocking drugs perhaps be harmful in the COVID-19 pandemic? J Hypertens. 2020;38. https:\/\/journals.lww.com\/jhypertension\/Fulltext\/2020\/05000\/Can_angiotensin_receptor_blocking_drugs_perhaps_be.2.aspx:781\u20132.","journal-title":"J Hypertens"},{"key":"1130_CR17","doi-asserted-by":"publisher","first-page":"1382","DOI":"10.1161\/HYPERTENSIONAHA.120.15082","volume":"75","author":"DAH Jan","year":"2020","unstructured":"Jan DAH, Murray E, Daniel B. Renin-angiotensin system blockers and the COVID-19 pandemic. Hypertension. 2020;75:1382\u20135. https:\/\/doi.org\/10.1161\/HYPERTENSIONAHA.120.15082.","journal-title":"Hypertension"},{"key":"1130_CR18","doi-asserted-by":"publisher","unstructured":"\u2022\u2022 Chung S-C, Providencia R, Sofat R. Association between angiotensin blockade and incidence of influenza in the United Kingdom. N Engl J Med (e-pub ahead of print 8 May 2020; https:\/\/doi.org\/10.1056\/NEJMc2005396. This paper studied a British databe to evaluate the incidence of influenza in a very large population of patients on various antihypertensive medications.","DOI":"10.1056\/NEJMc2005396"},{"key":"1130_CR19","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1016\/S2213-2600(14)70034-7","volume":"2","author":"AC Hayward","year":"2014","unstructured":"Hayward AC, Fragaszy EB, Bermingham A, Wang L, Copas A, Edmunds WJ, et al. Comparative community burden and severity of seasonal and pandemic influenza: results of the Flu Watch cohort study. Lancet Respir Med. 2014;2:445\u201354. https:\/\/doi.org\/10.1016\/S2213-2600(14)70034-7.","journal-title":"Lancet Respir Med"},{"key":"1130_CR20","doi-asserted-by":"publisher","first-page":"2088","DOI":"10.1093\/eurheartj\/ehs075","volume":"33","author":"LC van Vark","year":"2012","unstructured":"van Vark LC, Bertrand M, Akkerhuis KM, Brugts JJ, Fox K, Mourad J-J, et al. Angiotensin-converting enzyme inhibitors reduce mortality in hypertension: a meta-analysis of randomized clinical trials of renin-angiotensin-aldosterone system inhibitors involving 158,998 patients. Eur Heart J. 2012;33:2088\u201397. https:\/\/doi.org\/10.1093\/eurheartj\/ehs075.","journal-title":"Eur Heart J"},{"key":"1130_CR21","doi-asserted-by":"publisher","first-page":"1466","DOI":"10.1093\/cid\/cis733","volume":"55","author":"EM Mortensen","year":"2012","unstructured":"Mortensen EM, Nakashima B, Cornell J, Copeland LA, Pugh MJ, Anzueto A, et al. Population-based study of statins, angiotensin II receptor blockers, and angiotensin-converting enzyme inhibitors on pneumonia-related outcomes. Clin Infect Dis. 2012;55:1466\u201373. https:\/\/doi.org\/10.1093\/cid\/cis733.","journal-title":"Clin Infect Dis"},{"key":"1130_CR22","doi-asserted-by":"publisher","first-page":"1671","DOI":"10.1161\/CIRCRESAHA.120.317134","volume":"126","author":"P Zhang","year":"2020","unstructured":"\u2022 Zhang P, Zhu L, Cai J, Lei F, Qin J-J, Xie J, et al. Association of inpatient use of angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers with mortality among patients with hypertension hospitalized with COVID-19. Circ Res. 2020;126:1671\u201381. https:\/\/doi.org\/10.1161\/CIRCRESAHA.120.317134This study demonstrated a protective effect of ACEI in hospitalized patients with COVID 19.","journal-title":"Circ Res"},{"key":"1130_CR23","doi-asserted-by":"publisher","first-page":"1503 LP","DOI":"10.1136\/heartjnl-2020-317393","volume":"106","author":"J Hippisley-Cox","year":"2020","unstructured":"Hippisley-Cox J, Young D, Coupland C, Channon KM, Tan PS, Harrison DA, et al. Risk of severe COVID-19 disease with ACE inhibitors and angiotensin receptor blockers: cohort study including 8.3 million people. Heart. 2020;106:1503 LP\u20131511. https:\/\/doi.org\/10.1136\/heartjnl-2020-317393.","journal-title":"Heart"},{"key":"1130_CR24","doi-asserted-by":"publisher","first-page":"2441","DOI":"10.1056\/NEJMoa2008975","volume":"382","author":"HR Reynolds","year":"2020","unstructured":"Reynolds HR, Adhikari S, Pulgarin C, Troxel AB, Iturrate E, Johnson SB, et al. Renin\u2013angiotensin\u2013aldosterone system inhibitors and risk of covid-19. N Engl J Med. 2020;382:2441\u20138. https:\/\/doi.org\/10.1056\/NEJMoa2008975.","journal-title":"N Engl J Med"},{"key":"1130_CR25","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2007621","volume":"382","author":"MR Mehra","year":"2020","unstructured":"Mehra MR, Desai SS, Kuy SR, Henry TD, Patel AN. Cardiovascular disease, drug therapy, and mortality in COVID-19. N Engl J Med. 2020;382:E102. https:\/\/doi.org\/10.1056\/NEJMoa2007621.","journal-title":"N Engl J Med"},{"key":"1130_CR26","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1016\/j.trsl.2014.11.007","volume":"166","author":"B Yi","year":"2015","unstructured":"Yi B, Titze J, Rykova M, Feuerecker M, Vassilieva G, Nichiporuk I, et al. Effects of dietary salt levels on monocytic cells and immune responses in healthy human subjects: a longitudinal study. Transl Res. 2015;166:103\u201310. https:\/\/doi.org\/10.1016\/j.trsl.2014.11.007.","journal-title":"Transl Res"},{"key":"1130_CR27","doi-asserted-by":"publisher","first-page":"1194","DOI":"10.1161\/ATVBAHA.111.242719","volume":"32","author":"S Morizane","year":"2012","unstructured":"Morizane S, Mitani F, Ozawa K, Ito K, Matsuhashi T, Katsumata Y, et al. Biphasic time course of the changes in aldosterone biosynthesis under high-salt conditions in Dahl salt-sensitive rats. Arterioscler Thromb Vasc Biol. 2012;32:1194\u2013203. https:\/\/doi.org\/10.1161\/ATVBAHA.111.242719.","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"1130_CR28","doi-asserted-by":"publisher","unstructured":"\u2022 Yartas Dumanli G, Dilken O, Urkmez S. Use of spironolactone in SARS-CoV-2 ARDS patients. Turkish J Anaesthesiol Reanim (e-pub ahead of print 4 May 2020); https:\/\/doi.org\/10.5152\/TJAR.2020.569. This paper supports the idea that sodium depletion may improve outcomes in infectious diseases.","DOI":"10.5152\/TJAR.2020.569"},{"key":"1130_CR29","doi-asserted-by":"publisher","first-page":"254","DOI":"10.5152\/TJAR.2020.569","volume":"48","author":"GY Dumanli","year":"2020","unstructured":"Dumanli GY, Dilken O, Urkmez S. Use of spironolactone in SARS-CoV-2 ARDS patients. Turkish J Anaesthesiol Reanim. 2020;48:254.","journal-title":"Turkish J Anaesthesiol Reanim"},{"key":"1130_CR30","doi-asserted-by":"publisher","first-page":"586","DOI":"10.1007\/s00134-020-05985-9","volume":"2","author":"H Zhang","year":"2020","unstructured":"Zhang H, Penninger JM, Li Y, Zhong N, Slutsky AS. Angiotensin-converting enzyme 2 (ACE2) as a SARS-CoV-2 receptor: molecular mechanisms and potential therapeutic target. Intensive Care Med. 2020;2:586\u201390. https:\/\/doi.org\/10.1007\/s00134-020-05985-9.","journal-title":"Intensive Care Med"},{"key":"1130_CR31","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3949\/CCJM.87A.CCC049","volume":"87","author":"S El Ouali","year":"2020","unstructured":"El Ouali S, Achkar JP, Lashner B, Regueiro M. Gastrointestinal manifestations of COVID-19 Posted June 15, 2020. Cleve Clin J Med. 2020;87:1\u20134. https:\/\/doi.org\/10.3949\/CCJM.87A.CCC049.","journal-title":"Cleve Clin J Med"},{"key":"1130_CR32","doi-asserted-by":"publisher","first-page":"e382","DOI":"10.1002\/bjs.11821","volume":"107","author":"Y Zhao","year":"2020","unstructured":"Zhao Y, Cao Y, Wang S, Cai K, Xu K. COVID-19 and gastrointestinal symptoms. Br J Surg. 2020;107:e382\u20133. https:\/\/doi.org\/10.1002\/bjs.11821.","journal-title":"Br J Surg"},{"key":"1130_CR33","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1053\/j.gastro.2020.04.017","volume":"159","author":"YR Nobel","year":"2020","unstructured":"Nobel YR, Phipps M, Zucker J, Lebwohl B, Wang TC, Sobieszczyk ME, et al. Gastrointestinal symptoms and coronavirus disease 2019: a case-control study from the United States. Gastroenterology. 2020;159:373\u2013375.e2. https:\/\/doi.org\/10.1053\/j.gastro.2020.04.017.","journal-title":"Gastroenterology"},{"key":"1130_CR34","doi-asserted-by":"publisher","first-page":"938","DOI":"10.1136\/jcp.36.8.938","volume":"36","author":"PR Studdy","year":"1983","unstructured":"Studdy PR, Lapworth R, Bird R. Angiotensin-converting enzyme and its clinical significance--a review. J Clin Pathol. 1983;36:938\u201347. https:\/\/doi.org\/10.1136\/jcp.36.8.938.","journal-title":"J Clin Pathol"},{"key":"1130_CR35","doi-asserted-by":"publisher","first-page":"1636","DOI":"10.1016\/j.cgh.2020.03.043","volume":"18","author":"S Luo","year":"2020","unstructured":"Luo S, Zhang X, Xu H. Don\u2019t overlook digestive symptoms in patients with 2019 novel coronavirus disease (COVID-19). Clin Gastroenterol Hepatol. 2020;18:1636\u20137. https:\/\/doi.org\/10.1016\/j.cgh.2020.03.043.","journal-title":"Clin Gastroenterol Hepatol"},{"key":"1130_CR36","doi-asserted-by":"publisher","first-page":"938","DOI":"10.1136\/jcp.36.8.938","volume":"36","author":"PR Studdy","year":"1983","unstructured":"Studdy PR, Lapworth R, Bird R. Angiotensin-converting enzyme and its clinical significance--a review. J Clin Pathol. 1983;36:938\u201347. https:\/\/doi.org\/10.1136\/jcp.36.8.938.","journal-title":"J Clin Pathol"},{"key":"1130_CR37","doi-asserted-by":"publisher","unstructured":"Kirabo A, Barbaro N, Foss JD, Montaniel KR, Chen W, Harrison DG. High salt activates human monocytes and promotes their conversion into dendritic cells via formation of immunogenic isoketal-adducts. FASEB J. 2016;30:1216.4\u20134. https:\/\/doi.org\/10.1096\/fasebj.30.1_supplement.1216.4.","DOI":"10.1096\/fasebj.30.1_supplement.1216.4"},{"key":"1130_CR38","doi-asserted-by":"publisher","first-page":"2775","DOI":"10.1097\/01.asn.0000092145.90389.65","volume":"14","author":"C Kitiyakara","year":"2003","unstructured":"Kitiyakara C, Chabrashvili T, Chen Y, Blau J, Karber A, Aslam S, et al. Salt intake, oxidative stress, and renal expression of NADPH oxidase and superoxide dismutase. J Am Soc Nephrol. 2003;14:2775\u201382. https:\/\/doi.org\/10.1097\/01.asn.0000092145.90389.65.","journal-title":"J Am Soc Nephrol"},{"key":"1130_CR39","doi-asserted-by":"publisher","first-page":"893","DOI":"10.1038\/cr.2015.87","volume":"25","author":"W-C Zhang","year":"2015","unstructured":"Zhang W-C, Zheng X-J, Du L-J, Sun J-Y, Shen Z-X, Shi C, et al. High salt primes a specific activation state of macrophages, M (Na). Cell Res. 2015;25:893\u2013910. https:\/\/doi.org\/10.1038\/cr.2015.87.","journal-title":"Cell Res"},{"key":"1130_CR40","doi-asserted-by":"publisher","first-page":"5167","DOI":"10.1093\/hmg\/ddw331","volume":"25","author":"JA Chadwick","year":"2016","unstructured":"Chadwick JA, Swager SA, Lowe J, Welc SS, Tidball JG, Gomez-Sanchez CE, et al. Myeloid cells are capable of synthesizing aldosterone to exacerbate damage in muscular dystrophy. Hum Mol Genet. 2016;25:5167\u201377. https:\/\/doi.org\/10.1093\/hmg\/ddw331.","journal-title":"Hum Mol Genet"},{"key":"1130_CR41","doi-asserted-by":"publisher","first-page":"4020","DOI":"10.1038\/s41598-018-22156-5","volume":"8","author":"Y Wang","year":"2018","unstructured":"Wang Y, Luo L, Braun OO, Westman J, Madhi R, Herwald H, et al. Neutrophil extracellular trap-microparticle complexes enhance thrombin generation via the intrinsic pathway of coagulation in mice. Sci Rep. 2018;8:4020. https:\/\/doi.org\/10.1038\/s41598-018-22156-5.","journal-title":"Sci Rep"},{"key":"1130_CR42","doi-asserted-by":"publisher","first-page":"100741","DOI":"10.1016\/j.jbior.2020.100741","volume":"77","author":"G Sch\u00f6nrich","year":"2020","unstructured":"\u2022 Sch\u00f6nrich G, Raftery MJ, Samstag Y. Devilishly radical NETwork in COVID-19: oxidative stress, neutrophil extracellular traps (NETs), and T cell suppression. Adv Biol Regul. 2020;77:100741. https:\/\/doi.org\/10.1016\/j.jbior.2020.100741This paper discusses the role of immune mechanisms in COVID-19 including the rarely mentioned importance of NETs.","journal-title":"Adv Biol Regul"},{"key":"1130_CR43","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1038\/s41577-020-0331-4","volume":"20","author":"M Merad","year":"2020","unstructured":"Merad M, Martin JC. Pathological inflammation in patients with COVID-19: a key role for monocytes and macrophages. Nat Rev Immunol. 2020;20:355\u201362. https:\/\/doi.org\/10.1038\/s41577-020-0331-4.","journal-title":"Nat Rev Immunol"},{"key":"1130_CR44","doi-asserted-by":"publisher","first-page":"3595","DOI":"10.1038\/ncomms4595","volume":"5","author":"F Huang","year":"2014","unstructured":"Huang F, Guo J, Zou Z, Liu J, Cao B, Zhang S, et al. Angiotensin II plasma levels are linked to disease severity and predict fatal outcomes in H7N9-infected patients. Nat Commun. 2014;5:3595. https:\/\/doi.org\/10.1038\/ncomms4595.","journal-title":"Nat Commun"},{"key":"1130_CR45","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1016\/j.drudis.2010.11.016","volume":"16","author":"C Dasgupta","year":"2011","unstructured":"Dasgupta C, Zhang L. Angiotensin II receptors and drug discovery in cardiovascular disease. Drug Discov Today. 2011;16:22\u201334. https:\/\/doi.org\/10.1016\/j.drudis.2010.11.016.","journal-title":"Drug Discov Today"},{"key":"1130_CR46","doi-asserted-by":"publisher","first-page":"F1124","DOI":"10.1152\/ajprenal.00305.2011","volume":"301","author":"SD Crowley","year":"2011","unstructured":"Crowley SD, Zhang J, Herrera M, Griffiths R, Ruiz P, Coffman TM. Role of AT 1 receptor-mediated salt retention in angiotensin II-dependent hypertension. Am J Physiol Physiol. 2011;301:F1124\u201330. https:\/\/doi.org\/10.1152\/ajprenal.00305.2011.","journal-title":"Am J Physiol Physiol"},{"key":"1130_CR47","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1042\/CS20110403","volume":"123","author":"S Bernardi","year":"2012","unstructured":"\u2022\u2022 Bernardi S, Burns WC, Toffoli B, Pickering R, Sakoda M, Tsorotes D, et al. Angiotensin-converting enzyme 2 regulates renal atrial natriuretic peptide through angiotensin-(1-7). Clin Sci (Lond). 2012;123:29\u201337. https:\/\/doi.org\/10.1042\/CS20110403This paper describes many iatrogenic mechanisms responsible for metabolic alkalosis and puts them in a clinical perspective.","journal-title":"Clin Sci (Lond)"},{"key":"1130_CR48","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1038\/hr.2009.74","volume":"32","author":"M Iwai","year":"2009","unstructured":"Iwai M, Horiuchi M. Devil and angel in the renin\u2013angiotensin system: ACE\u2013angiotensin II\u2013AT1 receptor axis vs. ACE2\u2013angiotensin-(1\u20137)\u2013Mas receptor axis. Hypertens Res. 2009;32:533\u20136. https:\/\/doi.org\/10.1038\/hr.2009.74.","journal-title":"Hypertens Res"},{"key":"1130_CR49","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1038\/hr.2009.74","volume":"32","author":"M Iwai","year":"2009","unstructured":"Iwai M, Horiuchi M. Devil and angel in the renin\u2013angiotensin system: ACE\u2013angiotensin II\u2013AT1 receptor axis vs. ACE2\u2013angiotensin-(1\u20137)\u2013Mas receptor axis. Hypertens Res. 2009;32:533\u20136. https:\/\/doi.org\/10.1038\/hr.2009.74.","journal-title":"Hypertens Res"},{"key":"1130_CR50","doi-asserted-by":"publisher","first-page":"L17","DOI":"10.1152\/ajplung.00498.2016","volume":"314","author":"CP Sodhi","year":"2018","unstructured":"Sodhi CP, Wohlford-Lenane C, Yamaguchi Y, Prindle T, Fulton WB, Wang S, et al. Attenuation of pulmonary ACE2 activity impairs inactivation of des-arg9 bradykinin\/BKB1R axis and facilitates LPS-induced neutrophil infiltration. Am J Phys Lung Cell Mol Phys. 2018;314:L17\u201331. https:\/\/doi.org\/10.1152\/ajplung.00498.2016.","journal-title":"Am J Phys Lung Cell Mol Phys"},{"key":"1130_CR51","doi-asserted-by":"publisher","first-page":"1990","DOI":"10.1097\/01.ASN.0000078960.15147.05","volume":"14","author":"PN Chander","year":"2003","unstructured":"Chander PN, Rocha R, Ranaudo J, Singh G, Zuckerman A, Stier CT. Aldosterone plays a pivotal role in the pathogenesis of thrombotic microangiopathy in SHRSP. J Am Soc Nephrol. 2003;14:1990\u20137. https:\/\/doi.org\/10.1097\/01.ASN.0000078960.15147.05.","journal-title":"J Am Soc Nephrol"},{"key":"1130_CR52","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1097\/med.0b013e3283391989","volume":"17","author":"KC Gilbert","year":"2010","unstructured":"Gilbert KC, Brown NJ. Aldosterone and inflammation. Curr Opin Endocrinol Diabetes Obes. 2010;17:199\u2013204. https:\/\/doi.org\/10.1097\/med.0b013e3283391989.","journal-title":"Curr Opin Endocrinol Diabetes Obes"},{"key":"1130_CR53","doi-asserted-by":"publisher","first-page":"946","DOI":"10.1161\/01.RES.0000187500.24964.7A","volume":"97","author":"S Keidar","year":"2005","unstructured":"Keidar S, Gamliel-Lazarovich A, Kaplan M, Pavlotzky E, Hamoud S, Hayek T, et al. Mineralocorticoid receptor blocker increases angiotensin-converting enzyme 2 activity in congestive heart failure patients. Circ Res. 2005;97:946\u201353. https:\/\/doi.org\/10.1161\/01.RES.0000187500.24964.7A.","journal-title":"Circ Res"},{"key":"1130_CR54","doi-asserted-by":"publisher","first-page":"E587","DOI":"10.1152\/ajpendo.00136.2020","volume":"318","author":"FA Cadegiani","year":"2020","unstructured":"Cadegiani FA. Can spironolactone be used to prevent COVID-19-induced acute respiratory distress syndrome in patients with hypertension? Am J Physiol Endocrinol Metab. 2020;318:E587\u20138. https:\/\/doi.org\/10.1152\/ajpendo.00136.2020.","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"1130_CR55","doi-asserted-by":"publisher","unstructured":"Emmett M. Metabolic alkalosis: a brief pathophysiologic review. Clin J Am Soc Nephrol. 2020:1\u20139. https:\/\/doi.org\/10.2215\/CJN.16041219.","DOI":"10.2215\/CJN.16041219"},{"key":"1130_CR56","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1007\/BF00196851","volume":"47","author":"B Hasselgren","year":"1995","unstructured":"Hasselgren B, Johansson P. Natriuretic and diuretic effects of felodipine and hydrochlorothiazide after single and repeated doses. Eur J Clin Pharmacol. 1995;47:395\u2013400. https:\/\/doi.org\/10.1007\/BF00196851.","journal-title":"Eur J Clin Pharmacol"},{"key":"1130_CR57","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1016\/S0140-6736(87)91074-9","volume":"330","author":"A Richardson","year":"1987","unstructured":"Richardson A, Scriven AJ, Poole-Wilson PA, Bayliss J, Parameshwar J, Sutton GC. Double-blind comparison of captopril alone against frusemide plus amiloride in mild heart failure. Lancet. 1987;330:709\u201311. https:\/\/doi.org\/10.1016\/S0140-6736(87)91074-9.","journal-title":"Lancet"},{"key":"1130_CR58","doi-asserted-by":"publisher","first-page":"2441","DOI":"10.1056\/NEJMoa2008975","volume":"382","author":"HR Reynolds","year":"2020","unstructured":"Reynolds HR, Adhikari S, Pulgarin C, Troxel AB, Iturrate E, Johnson SB, et al. Renin\u2013angiotensin\u2013aldosterone system inhibitors and risk of Covid-19. N Engl J Med. 2020;382:2441\u20138. https:\/\/doi.org\/10.1056\/NEJMoa2008975.","journal-title":"N Engl J Med"},{"key":"1130_CR59","doi-asserted-by":"publisher","first-page":"978","DOI":"10.1016\/S0895-7061(01)02178-1","volume":"14","author":"FH Messerli","year":"2001","unstructured":"Messerli FH. Vasodilatory edema: a common side effect of antihypertensive therapy. Am J Hypertens. 2001;14:978\u20139.","journal-title":"Am J Hypertens"},{"key":"1130_CR60","doi-asserted-by":"publisher","first-page":"1182","DOI":"10.1016\/S0002-9149(00)01199-1","volume":"86","author":"FH Messerli","year":"2000","unstructured":"Messerli FH, Oparil S, Feng Z. Comparison of efficacy and side effects of combination therapy of angiotensin-converting enzyme inhibitor (benazepril) with calcium antagonist (either nifedipine or amlodipine) versus high-dose calcium antagonist monotherapy for systemic hypertension. Am J Cardiol. 2000;86:1182\u20137. https:\/\/doi.org\/10.1016\/S0002-9149(00)01199-1.","journal-title":"Am J Cardiol"},{"key":"1130_CR61","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1005738","volume":"12","author":"H Puerta-Guardo","year":"2016","unstructured":"Puerta-Guardo H, Glasner DR, Harris E. Dengue virus NS1 disrupts the endothelial glycocalyx, leading to hyperpermeability. PLoS Pathog. 2016;12:e1005738. https:\/\/doi.org\/10.1371\/journal.ppat.1005738.","journal-title":"PLoS Pathog"},{"key":"1130_CR62","unstructured":"Benatti MN, Borges MDC, Miranda CH. Endothelial glycocalyx damage in the early phase of acute respiratory distress syndrome secondary to respiratory virus infection. 2016; 18: 6736."},{"key":"1130_CR63","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1165\/rcmb.2018-0108ED","volume":"59","author":"S Weidenfeld","year":"2018","unstructured":"Weidenfeld S, Kuebler WM. Shedding first light on the alveolar epithelial glycocalyx. Am J Respir Cell Mol Biol. 2018;59:283\u20134. https:\/\/doi.org\/10.1165\/rcmb.2018-0108ED.","journal-title":"Am J Respir Cell Mol Biol"},{"key":"1130_CR64","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1002\/path.1570","volume":"203","author":"I Hamming","year":"2004","unstructured":"Hamming I, Timens W, Bulthuis MLC, Lely AT, Navis GJ, van Goor H. Tissue distribution of ACE2 protein, the functional receptor for SARS coronavirus. A first step in understanding SARS pathogenesis. J Pathol. 2004;203:631\u20137. https:\/\/doi.org\/10.1002\/path.1570.","journal-title":"J Pathol"},{"key":"1130_CR65","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1093\/ckj\/sfz042","volume":"12","author":"O Yilmaz","year":"2019","unstructured":"Yilmaz O, Afsar B, Ortiz A, Kanbay M. The role of endothelial glycocalyx in health and disease. Clin Kidney J. 2019;12:611\u20139. https:\/\/doi.org\/10.1093\/ckj\/sfz042.","journal-title":"Clin Kidney J"},{"key":"1130_CR66","doi-asserted-by":"publisher","first-page":"2052","DOI":"10.1001\/jama.2020.6775","volume":"323","author":"S Richardson","year":"2020","unstructured":"Richardson S, Hirsch JS, Narasimhan M, Crawford JM, McGinn T, Davidson KW, et al. Presenting characteristics, comorbidities, and outcomes among 5700 patients hospitalized with COVID-19 in the New York City area. JAMA. 2020;323:2052\u20139. https:\/\/doi.org\/10.1001\/jama.2020.6775.","journal-title":"JAMA"},{"key":"1130_CR67","doi-asserted-by":"publisher","first-page":"546","DOI":"10.1038\/s41581-019-0167-y","volume":"15","author":"N Wilck","year":"2019","unstructured":"Wilck N, Balogh A, Mark\u00f3 L, Bartolomaeus H, M\u00fcller DN. The role of sodium in modulating immune cell function. Nat Rev Nephrol. 2019;15:546\u201358. https:\/\/doi.org\/10.1038\/s41581-019-0167-y.","journal-title":"Nat Rev Nephrol"},{"key":"1130_CR68","doi-asserted-by":"publisher","first-page":"466","DOI":"10.1007\/s11239-019-01879-w","volume":"48","author":"M Bachler","year":"2019","unstructured":"Bachler M, Niederwanger C, Hell T, H\u00f6fer J, Gerstmeyr D, Schenk B, et al. Influence of factor XII deficiency on activated partial thromboplastin time (aPTT) in critically ill patients. J Thromb Thrombolysis. 2019;48:466\u201374. https:\/\/doi.org\/10.1007\/s11239-019-01879-w.","journal-title":"J Thromb Thrombolysis"},{"key":"1130_CR69","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1111\/aas.12418","volume":"59","author":"S Yini","year":"2015","unstructured":"Yini S, Heng Z, Xin A, Xiaochun M. Effect of unfractionated heparin on endothelial glycocalyx in a septic shock model. Acta Anaesthesiol Scand. 2015;59:160\u20139. https:\/\/doi.org\/10.1111\/aas.12418.","journal-title":"Acta Anaesthesiol Scand"},{"key":"1130_CR70","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1177\/0310057x1704500305","volume":"45","author":"NL Pillinger","year":"2017","unstructured":"Pillinger NL, Kam PCA. Endothelial glycocalyx: basic science and clinical implications. Anaesth Intensive Care. 2017;45:295\u2013307. https:\/\/doi.org\/10.1177\/0310057x1704500305.","journal-title":"Anaesth Intensive Care"},{"key":"1130_CR71","doi-asserted-by":"publisher","unstructured":"Horby P, Lim WS, Emberson JR, Mafham M, Bell JL, Linsell L, Staplin N, Brightling C, Ustianowski A, Elmahi E, Prudon B, Green C, Felton T, Chadwick D, Rege K, Fegan C, Chappell LC, Faust SN, Jaki T, Jeffery K, Montgomery A, Rowan K, Juszczak E, Baillie JK, Haynes R, Landray MJ. Dexamethasone in hospitalized patients with Covid-19 - preliminary report. N Engl J Med (e-pub ahead of print July 2020); https:\/\/doi.org\/10.1056\/NEJMoa2021436.","DOI":"10.1056\/NEJMoa2021436"},{"key":"1130_CR72","doi-asserted-by":"publisher","first-page":"1239","DOI":"10.1001\/jama.2020.2648","volume":"323","author":"Z Wu","year":"2020","unstructured":"Wu Z, McGoogan JM. Characteristics of and important lessons from the Coronavirus Disease 2019 (COVID-19) outbreak in china: summary of a report of 72 314 cases from the Chinese Center for Disease Control and Prevention. JAMA. 2020;323:1239\u201342. https:\/\/doi.org\/10.1001\/jama.2020.2648.","journal-title":"JAMA"},{"key":"1130_CR73","doi-asserted-by":"publisher","first-page":"F3","DOI":"10.1097\/QAD.0000000000002666","volume":"34","author":"YB Hadi","year":"2020","unstructured":"Hadi YB, Naqvi SFZ, Kupec JT, Sarwari AR. Characteristics and outcomes of COVID-19 in patients with HIV: a multicentre research network study. AIDS. 2020;34.https:\/\/journals.lww.com\/aidsonline\/Fulltext\/2020\/11010\/Characteristics_and_outcomes_of_COVID_19_in.1.aspx:F3\u20138.","journal-title":"AIDS"},{"key":"1130_CR74","doi-asserted-by":"publisher","first-page":"424","DOI":"10.1186\/s13104-019-4470-2","volume":"12","author":"SK Masenga","year":"2019","unstructured":"Masenga SK, Hamooya BM, Nzala S, Kwenda G, Heimburger DC, Mutale W, et al. HIV, immune activation and salt-sensitive hypertension (HISH): a research proposal. BMC Res Notes. 2019;12:424. https:\/\/doi.org\/10.1186\/s13104-019-4470-2.","journal-title":"BMC Res Notes"},{"key":"1130_CR75","doi-asserted-by":"publisher","unstructured":"Ackermann M, Verleden SE, Kuehnel M, Haverich A, Welte T, Laenger F, Vanstapel A, Werlein C, Stark H, Tzankov A, Li WW, Li VW, Mentzer SJ, Jonigk D. Pulmonary vascular endothelialitis, thrombosis, and angiogenesis in Covid-19. N Engl J Med 2020; NEJMoa2015432. https:\/\/doi.org\/10.1056\/NEJMoa2015432","DOI":"10.1056\/NEJMoa2015432"},{"key":"1130_CR76","first-page":"571","volume":"56","author":"M Kami\u0144ska","year":"2005","unstructured":"Kami\u0144ska M, Mogielnicki A, Stankiewicz A, Kramkowski K, Domaniewski T, Buczko W, et al. Angiotensin II via AT1 receptor accelerates arterial thrombosis in renovascular hypertensive rats. J Physiol Pharmacol Off J Polish Physiol Soc. 2005;56:571\u201385.","journal-title":"J Physiol Pharmacol Off J Polish Physiol Soc"},{"key":"1130_CR77","doi-asserted-by":"publisher","first-page":"210","DOI":"10.2119\/molmed.2009.00160","volume":"16","author":"RA Fraga-Silva","year":"2010","unstructured":"Fraga-Silva RA, Sorg BS, Wankhede M, Dedeugd C, Jun JY, Baker MB, et al. ACE2 activation promotes antithrombotic activity. Mol Med. 2010;16:210\u20135. https:\/\/doi.org\/10.2119\/molmed.2009.00160.","journal-title":"Mol Med"},{"key":"1130_CR78","doi-asserted-by":"publisher","first-page":"642","DOI":"10.1016\/S0008-6363(00)00163-2","volume":"47","author":"L D\u00e9zsi","year":"2000","unstructured":"D\u00e9zsi L. Fibrinolytic actions of ACE inhibitors: a significant plus beyond antihypertensive therapeutic effects. Cardiovasc Res. 2000;47:642\u20134. https:\/\/doi.org\/10.1016\/S0008-6363(00)00163-2.","journal-title":"Cardiovasc Res"},{"key":"1130_CR79","doi-asserted-by":"publisher","unstructured":"Chae YK, Khemasuwan D, Dimou A, Neagu S, Chebrolu L, Gupta S, et al. Inhibition of renin angiotensin axis may be associated with reduced risk of developing venous thromboembolism in patients with atherosclerotic disease. PLoS One. 2014;9:e87813\u20133. https:\/\/doi.org\/10.1371\/journal.pone.0087813.","DOI":"10.1371\/journal.pone.0087813"},{"key":"1130_CR80","doi-asserted-by":"publisher","unstructured":"Paranjpe I, Fuster V, Lala A, Russak A, Glicksberg BS, Levin MA, et al. Association of treatment dose anticoagulation with in-hospital survival among hospitalized patients with COVID-19. J Am Coll Cardiol (e-pub ahead of print). 2020. https:\/\/doi.org\/10.1016\/j.jacc.2020.05.001.","DOI":"10.1016\/j.jacc.2020.05.001"},{"key":"1130_CR81","doi-asserted-by":"publisher","first-page":"743","DOI":"10.1016\/j.thromres.2006.10.026","volume":"122","author":"E Young","year":"2008","unstructured":"Young E. The anti-inflammatory effects of heparin and related compounds. Thromb Res. 2008;122:743\u201352. https:\/\/doi.org\/10.1016\/j.thromres.2006.10.026.","journal-title":"Thromb Res"},{"key":"1130_CR82","doi-asserted-by":"publisher","first-page":"5774","DOI":"10.1021\/bi800205t","volume":"47","author":"R Copeland","year":"2008","unstructured":"Copeland R, Balasubramaniam A, Tiwari V, Zhang F, Bridges A, Linhardt RJ, et al. Using a 3-O-sulfated heparin octasaccharide to inhibit the entry of herpes simplex virus type 1. Biochemistry. 2008;47:5774\u201383. https:\/\/doi.org\/10.1021\/bi800205t.","journal-title":"Biochemistry"},{"key":"1130_CR83","doi-asserted-by":"publisher","first-page":"1727","DOI":"10.2217\/nnm-2017-0127","volume":"12","author":"CR Al\u00e1ez-Vers\u00f3n","year":"2017","unstructured":"Al\u00e1ez-Vers\u00f3n CR, Lantero E, Fern\u00e0ndez-Busquets X. Heparin: new life for an old drug. Nanomedicine (London). 2017;12:1727\u201344. https:\/\/doi.org\/10.2217\/nnm-2017-0127.","journal-title":"Nanomedicine (London)"},{"key":"1130_CR84","doi-asserted-by":"publisher","first-page":"507151","DOI":"10.1155\/2015\/507151","volume":"2015","author":"S Mousavi","year":"2015","unstructured":"Mousavi S, Moradi M, Khorshidahmad T, Motamedi M. Anti-inflammatory effects of heparin and its derivatives: a systematic review. Adv Pharmacol Sci. 2015;2015:507151\u201314. https:\/\/doi.org\/10.1155\/2015\/507151.","journal-title":"Adv Pharmacol Sci"}],"container-title":["Current Hypertension Reports"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11906-021-01130-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11906-021-01130-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11906-021-01130-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,3,17]],"date-time":"2021-03-17T18:40:52Z","timestamp":1616006452000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11906-021-01130-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,2]]},"references-count":84,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2021,2]]}},"alternative-id":["1130"],"URL":"https:\/\/doi.org\/10.1007\/s11906-021-01130-z","relation":{},"ISSN":["1522-6417","1534-3111"],"issn-type":[{"value":"1522-6417","type":"print"},{"value":"1534-3111","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,2]]},"assertion":[{"value":"26 January 2021","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 February 2021","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with Ethical Standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}},{"value":"This article does not contain any studies with human or animal subjects performed by any of the authors.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Human and Animal Rights and Informed Consent"}},{"value":"This content has been made available to all.","name":"free","label":"Free to read"}],"article-number":"12"}}